Early Adverse Events between mRNA and Adenovirus-Vectored COVID-19 Vaccines in Healthcare Workers
Mass vaccination campaigns are important to control the COVID-19 pandemic, however, adverse events (AEs) contribute to vaccine hesitancy. To investigate and compare early AEs between the BNT162b2 mRNA and AZD1222 adenovirus-vectored vaccines, recipients completed daily surveys about local and system...
Main Authors: | Yu-Mi Wi, Si-Ho Kim, Kyong-Ran Peck |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/8/931 |
Similar Items
-
Adverse Events Associated with BNT162b2 and AZD1222 Vaccines in the Real World: Surveillance Report in a Single Italian Vaccine Center
by: Maria Costantino, et al.
Published: (2022-03-01) -
Outcomes of single dose COVID-19 vaccines: Eight month follow-up of a large cohort in Saudi Arabia
by: Naif Khalaf Alharbi, et al.
Published: (2022-05-01) -
Immunization and SARS-CoV-2 Antibody Seroprevalence in a Country with High Vaccination Coverage: Lessons from Chile
by: Ximena Aguilera, et al.
Published: (2022-06-01) -
SARS-CoV-2 Neutralizing Antibodies in Chile after a Vaccination Campaign with Five Different Schemes
by: Ximena Aguilera, et al.
Published: (2022-06-01) -
Persistence of Anti-SARS-CoV-2 Spike IgG Antibodies Following COVID-19 Vaccines
by: Alharbi NK, et al.
Published: (2022-07-01)